These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20078621)

  • 1. The atrial fibrillation paradox of heart failure.
    Shelton RJ; Clark AL; Kaye GC; Cleland JG
    Congest Heart Fail; 2010; 16(1):3-9. PubMed ID: 20078621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
    J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
    Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation (AF) and heart failure (HF): to treat the AF, be sure to treat the HF.
    Prudente LA
    Prog Cardiovasc Nurs; 2008; 23(3):146-9. PubMed ID: 19039898
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation.
    Suzuki S; Sagara K; Otsuka T; Matsuno S; Funada R; Uejima T; Oikawa Y; Yajima J; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
    Am J Cardiol; 2012 Sep; 110(5):678-82. PubMed ID: 22621797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation.
    Boldt LH; Rolf S; Huemer M; Parwani AS; Luft FC; Dietz R; Haverkamp W
    Am Heart J; 2008 May; 155(5):890-5. PubMed ID: 18440338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
    Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
    JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
    Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent prognostic significance of atrial fibrillation in outpatients with chronic heart failure: data from the Italian Network on Congestive Heart Failure Registry.
    Baldasseroni S; Orso F; Fabbri G; De Bernardi A; Cirrincione V; Gonzini L; Fumagalli S; Marchionni N; Midi P; Maggioni AP;
    Cardiology; 2010; 116(2):79-88. PubMed ID: 20516683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment for incident heart failure in individuals with atrial fibrillation.
    Schnabel RB; Rienstra M; Sullivan LM; Sun JX; Moser CB; Levy D; Pencina MJ; Fontes JD; Magnani JW; McManus DD; Lubitz SA; Tadros TM; Wang TJ; Ellinor PT; Vasan RS; Benjamin EJ
    Eur J Heart Fail; 2013 Aug; 15(8):843-9. PubMed ID: 23594831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study).
    Magaña-Serrano JA; Almahmeed W; Gomez E; Al-Shamiri M; Adgar D; Sosner P; Herpin D;
    Am J Cardiol; 2011 Nov; 108(9):1289-96. PubMed ID: 22000627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients.
    Puglisi A; Gasparini M; Lunati M; Sassara M; Padeletti L; Landolina M; Botto GL; Vincenti A; Bianchi S; Denaro A; Grammatico A; Boriani G;
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):693-701. PubMed ID: 18328039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and echocardiographic study.
    Fung JW; Sanderson JE; Yip GW; Zhang Q; Yu CM
    J Card Fail; 2007 Oct; 13(8):649-55. PubMed ID: 17923357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.